Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) subsidiary MindWave Innovations Inc. signed a 12-month technology services agreement with Singapore-based AQUAE Holdings Pte. Ltd. to deploy its MindChain infrastructure as the foundation of AQUAEChain, a platform for insured ALCI Credits. MindWave will design, develop, deploy and host AQUAEChain, which will manage the issuance, verification, tracking, transfer and retirement of ALCI Credits, and will provide ongoing technical support.
MindWave will receive contracted software development and technology service fees, while the agreement also references an allocation to MindWave equal to 20% of total ALCI Credits issued and outstanding on the AQUAEChain network, calculated quarterly using the MindChain issuance ledger. Following the initial 12-month term, the parties expect to move to a five-year continuing technology services arrangement, subject to mutual agreement and definitive documentation.
To view the full press release, visit https://ibn.fm/Hpsye
About Apimeds Pharmaceuticals US, Inc.
Apimeds Pharmaceuticals US, Inc. is a clinical-stage biopharmaceutical company focused on developing non-opioid, biologic-based therapies for pain management. For more information, visit www.ApimedsUS.com.
About MindWave Innovations Inc.
MindWave Innovations Inc., a wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc., is developing enterprise blockchain infrastructure and institutional technology platforms through its MindChain ecosystem. Four ecosystems operate under MindChain: InsurTech through BlockAssure, which is developing a Bermuda-framework platform applying Bitcoin reserves as regulatory capital to support life and property and casualty underwriting; ClimateTech through AQUAE and the ALCI index, measuring, verifying and tokenizing ecosystem services into institutional-grade assets; HealthTech through the Apitox development program; and RWA Tech through Nexus Global Partners, bringing institutional real estate on-chain within a compliance-first, insurance-enhanced framework.
NOTE TO INVESTORS: The latest news and updates relating to APUS are available in the company’s newsroom at https://ibn.fm/APUS
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]
InvestorWire is powered by IBN